The FDA is expected to grant Johnson & Johnson emergency-use authorization for its COVID-19 vaccine as early as Friday night.
The FDA is expected to grant Johnson & Johnson emergency-use authorization for its COVID-19 vaccine as early as Friday night.
The U.S. Food and Drug Administration has given the greenlight to Johnson & Johnson's single-shot COVID-19 vaccine.
The vaccine, still in the final federal approval process, has fewer handling restrictions than the Pfizer and Moderna vaccines now..